Armenia vs Macao: The number of people with susceptibility test result for rifampicin
Armenia
209
in 2021
Macao
193
in 2021
Armenia rank
93rd
Macao rank
95th
The number of people with susceptibility test result for rifampicin over time
- Armenia
- Macao
How they compare
Armenia currently reports 209 against 193 in Macao, a difference of 16.
That makes Armenia's figure about 1.1 times Macao's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Armenia ahead.
Armenia ranks 93rd and Macao ranks 95th of 155 countries.
Armenia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Armenia | Macao | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 267.67 | 220.33 | 47.33 | Armenia |
| 2020s | 203.5 | 201 | 2.5 | Armenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Armenia or Macao?
- Armenia, at 209 against 193 in Macao as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Armenia and Macao?
- 16, with Armenia ahead.
- How many years of comparable data are there for Armenia and Macao?
- 5 years are reported by both, from 2017 to 2021.
- How do Armenia and Macao rank globally for the number of people with susceptibility test result for rifampicin?
- Armenia ranks 93rd and Macao ranks 95th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.